These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8283665)

  • 1. [Medical treatment for cerebral vasospasm].
    Kanamaru K; Waga S; Murata H; Nakao K
    Nihon Rinsho; 1993 Nov; 51 Suppl():194-201. PubMed ID: 8283665
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical application of Ca2(+)-antagonist for prevention and treatment of cerebral vasospasm].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1989 Aug; 47(8):1831-6. PubMed ID: 2685399
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preventive drug therapy of transient cerebral ischemic attacks].
    Sørensen PS; Marquardsen J
    Ugeskr Laeger; 1982 Aug; 144(32):2357-60. PubMed ID: 7147462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm].
    Nishizawa Y
    Nihon Rinsho; 1993 Dec; 51 Suppl():389-96. PubMed ID: 8121018
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term anticoagulant therapy for transient ischemic attack and cerebral infarct with minor symptoms].
    Müller R; Olsson JE
    Lakartidningen; 1977 Nov; 74(45):3973-8. PubMed ID: 926938
    [No Abstract]   [Full Text] [Related]  

  • 7. Subarachnoid fibrinolytic treatment for the prevention of cerebral vasospasm.
    Findlay JM
    Semin Neurol; 1991 Dec; 11(4):400-10. PubMed ID: 1811295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transient ischemic cerebral disorders. Medical treatment].
    Géraud J; Bès A; Géraud G
    Rev Prat; 1977 Jan; 27(1):63-70. PubMed ID: 834943
    [No Abstract]   [Full Text] [Related]  

  • 9. [3GS prevention and therapy of transient cerebral ischemic attacks in the aged].
    Mancini M; Dall'Asta D; Maini C; Cucinotta D
    G Clin Med; 1983; 64(1-2):51-65. PubMed ID: 6345252
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of vasospasm with beta-mimetics: study of cerebral blood flow].
    Dematons C; Goldstein A; Muzard O; George B; Luft A; Raggueneau JL
    Agressologie; 1984 Jun; 25(7):823-6. PubMed ID: 6148901
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic strategy for vasospasm. Pharmacologic treatment].
    Viale G
    Minerva Anestesiol; 1998 May; 64(5):215-6. PubMed ID: 9773661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference: nimodipine in cerebral vasospasm.
    Dorsch NW; Little JM
    Neurosurgery; 1989 Jun; 24(6):959-60. PubMed ID: 2664549
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of prostacyclin on cerebral vasospasm--an experimental study].
    Quintana L; Konda R; Ishibashi Y; Okada H; Suzuki J
    No Shinkei Geka; 1982 Oct; 10(10):1049-52. PubMed ID: 6757779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of cerebral vasospasm caused by the rupture of intracranial aneurysms].
    Oliver Abadal B; Sagués Gabarró F; Bartumeus Jené F
    Rev Clin Esp; 1988 Feb; 182(3):163-5. PubMed ID: 3285383
    [No Abstract]   [Full Text] [Related]  

  • 15. Subarachnoid administration of phentolamine for experimental cerebral vasospasm.
    Flamm ES; Ransohoff J
    Surg Forum; 1972; 23(0):450-2. PubMed ID: 4671154
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of cerebral vasospasm by cisternal irrigation].
    Kodama N; Sasaki T; Yamanobe K
    Nihon Rinsho; 1988 Jan; 46(1):201-7. PubMed ID: 3286926
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphodiesterase inhibitors and cerebral vasospasm.
    Flamm ES; Kim J; Lin J; Ransohoff J
    Trans Am Neurol Assoc; 1974; 99():137-40. PubMed ID: 4377047
    [No Abstract]   [Full Text] [Related]  

  • 18. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow (CBF).
    Handa H; Nagasawa S; Yonekawa Y; Naruo Y; Oda Y
    Prog Clin Biol Res; 1983; 122():299-306. PubMed ID: 6878374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of cerebral vasospasm by thrombolytic therapy using t-PA].
    Miyamoto S; Kikuchi H; Nagata I
    Nihon Rinsho; 1993 Dec; 51 Suppl():404-6. PubMed ID: 8121020
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical lidocaine in treatment of cerebral vasospasm.
    Giannotta SL; Kindt GW; Haar FL
    Surg Neurol; 1975 Jul; 4(1):13-6. PubMed ID: 1166396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.